Blog · IoT & Connected Devices

    BLE Security in Medical Devices: What to Get Right

    BLE security for medical devices explained: pairing methods, attack classes, and what the February 3, 2026 FDA guidance expects documented.

    Abstract blue and white network nodes connect to a stylized medical device, illustrating BLE security
    On this page
    Christian Espinosa, Founder & CEO at Blue Goat Cyber

    By Christian Espinosa, MBA

    Founder & CEO · Blue Goat Cyber

    Published: · Updated:

    Key Takeaways

    • BLE security outcomes are determined by pairing method, key management, and GATT permissions, not by the fact that a device uses BLE.
    • Legacy pairing and Just Works remain exploitable in the field even though LE Secure Connections has existed since Bluetooth 4.2.
    • Unauthenticated GATT characteristics are one of the most common findings in medical device BLE assessments, exposing telemetry or configuration without any pairing at all.
    • Resolvable private addresses defeat casual tracking, but only if the device actually rotates them and the companion app does not defeat the purpose by logging static identifiers elsewhere.
    • Application-layer authentication and encryption, independent of the BLE link layer, is what limits damage when a link-layer pairing weakness is found later.
    • The FDA expects BLE-specific attack scenarios in the threat model, not a generic statement that encryption is used.
    Direct Answer

    BLE security in medical devices depends entirely on how pairing, bonding, and access control are configured, not on BLE itself. The protocol supports LE Secure Connections with authenticated pairing and per-device keys, but a device shipped with Just Works pairing, static long-term keys, or unauthenticated GATT characteristics is exposed to spoofing, MITM, and unauthorized read or write of therapy-relevant data. Manufacturers must threat model BLE-specific attack paths and document mitigations for the FDA's premarket cybersecurity review.

    Reviewed September 17, 2026

    BLE shows up in continuous glucose monitors, insulin pumps, hearing aids, patient monitors, and clinician programmers because it is low power and widely supported, not because it is inherently secure. That distinction matters because the same protocol that lets a device run for months on a coin cell can also expose therapy settings, telemetry, or firmware update channels if pairing and access control are left at default settings. A CGM broadcasting glucose values without link-layer encryption, or a programmer that accepts any device advertising a matching name, are configuration failures, not protocol failures. Manufacturers preparing an FDA submission need to show they evaluated BLE's specific pairing, bonding, and GATT permission model against realistic attacker capability, not assert that using BLE satisfies a security requirement on its own.

    Why This Matters

    The FDA's "Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions" final guidance, dated February 3, 2026, expects manufacturers to identify the specific communication interfaces on a device and analyze the attack surface each one introduces. BLE is treated as a distinct interface with its own pairing, bonding, and characteristic-level access control model, and a generic wireless security narrative does not satisfy that expectation. Reviewers look for evidence that the manufacturer considered how an attacker within radio range, not just an attacker with network access, could interact with the device.

    This matters because BLE's convenience, no cables, long battery life, broad phone compatibility, creates an attack surface that classic wired interfaces do not have. A device with a vulnerable BLE implementation can be attacked without ever touching the patient's network, simply by being physically nearby. AAMI SW96, FDA Recognized Consensus Standard 13-131, and IEC 81001-5-1 both expect wireless-specific risk analysis as part of the broader security risk management process, and BLE pairing and GATT design decisions are exactly the kind of detail that analysis has to cover.

    What Is BLE and How Does It Differ From Bluetooth Classic?

    BLE, or Bluetooth Low Energy, is a wireless protocol that shares the 2.4 GHz ISM band with Bluetooth Classic but uses a different stack designed for intermittent, low-power communication rather than continuous streaming. Bluetooth Classic maintains a persistent connection suited to audio and file transfer, which draws significantly more power. BLE instead uses short connection events and a client-server data model, which is why it dominates in battery-powered medical devices that need to report periodically rather than stream continuously.

    The two protocols are not interoperable at the radio or stack level, despite sharing a brand and frequency band. A device supporting BLE will not connect to a Bluetooth Classic-only peer, and security mechanisms, including pairing methods and key exchange, are defined separately for each.

    What Is the BLE Stack and GATT Model?

    The BLE stack organizes communication into layers, with the Generic Attribute Profile, GATT, defining how data is structured and exchanged between a central device, such as a phone or programmer, and a peripheral, such as a sensor or pump. GATT organizes data into services and characteristics, each with its own read, write, and notify permissions. A characteristic can be configured to require no security, unauthenticated pairing, or authenticated pairing with encryption before it can be accessed.

    [KEY REQUIREMENT] Every GATT characteristic that exposes therapy settings, calibration data, or firmware control must require authenticated encryption at the attribute permission level, not rely solely on the fact that the device paired successfully at connection time.

    Why Do Medical Devices Use BLE?

    Medical devices use BLE because it delivers months or years of battery life while still supporting periodic data exchange with a phone, gateway, or clinician programmer. Continuous glucose monitors and patient wearables use it to push readings to a companion app without daily charging. Insulin pumps and hearing aids use it for configuration and firmware updates from a paired device, and patient monitors and programmers use it to pull telemetry or push therapy adjustments in clinical settings. These use cases share a common risk profile: the data or commands passing over BLE often have direct clinical consequence if intercepted or forged.

    How Do BLE Pairing and Bonding Methods Compare?

    BLE pairing methods differ in how they establish a shared key and how resistant they are to interception or impersonation, and the difference between Legacy pairing and LE Secure Connections is the most consequential choice a manufacturer makes.

    MethodHow It WorksMITM ResistanceTypical Use
    Just WorksDevices agree on a key with no user verification stepNoneDevices with no display or input, high risk if used for sensitive characteristics
    Passkey EntryUser enters or compares a six-digit code on one or both devicesModerate, depends on entropy and side channelDevices with a keypad or simple display
    Numeric ComparisonBoth devices display a code the user confirms matchesStrong, when using LE Secure ConnectionsDevices with a screen, such as programmers
    Out of Band (OOB)Key material exchanged over a separate channel, such as NFCStrong, tied to physical proximityDevices with NFC or another secondary interface

    Legacy pairing, used before Bluetooth 4.2's LE Secure Connections, derives keys using a method vulnerable to passive eavesdropping if an attacker captures the pairing exchange. LE Secure Connections uses Elliptic Curve Diffie-Hellman, ECDH, key exchange instead, so a passive observer of the pairing process cannot derive the resulting long-term key even if they capture every packet. This is the single most important upgrade a legacy BLE implementation can make.

    What Are the Concrete BLE Attack Classes?

    BLE attacks target specific weaknesses in pairing, addressing, and the GATT access model, and most fall into a small number of well-documented classes. Passive sniffing of Legacy pairing exchanges lets an attacker with commodity sniffer hardware recover the long-term key without ever interacting with either device. A man-in-the-middle attack against Just Works pairing succeeds because Just Works provides no way for either party to confirm they are talking to the intended peer, so an attacker can relay or alter traffic during the pairing exchange itself.

    Spoofing and impersonation attacks exploit devices that authenticate only by advertised name or service UUID, letting an attacker's device masquerade as a legitimate sensor or programmer. KNOB and BLURtooth-class attacks manipulate key negotiation or cross-transport key derivation to force weaker encryption or reuse keys across Bluetooth Classic and BLE. GATT characteristic enumeration lets an attacker discover every exposed service on a device, and unauthenticated read or write access on any of those characteristics can leak telemetry or alter configuration without ever completing a real pairing. Replay attacks resend previously captured legitimate commands when a device does not track sequence numbers or freshness. Denial of service and battery drain attacks repeatedly trigger connection attempts or advertising responses to exhaust a battery-powered device faster than intended. Finally, tracking risk differs sharply between devices that broadcast a static MAC address, which lets an observer log a patient's device location over time, and devices using resolvable private addresses that rotate on a schedule known only to bonded peers.

    What Does Good BLE Security Look Like?

    Good BLE security combines LE Secure Connections with the strongest pairing method the device's I/O supports, Numeric Comparison or OOB where a display or secondary channel exists, and treats the link layer as one layer of defense rather than the only one. Application-layer authentication and encryption, independent of the BLE link, should protect any command or data that has clinical consequence, so that a link-layer pairing weakness discovered later does not expose the therapy path directly.

    [KEY REQUIREMENT] Devices should use per-device keys rather than a shared key baked into firmware across a product line, since a single extracted key from one compromised unit should never grant access to every other unit in the field.

    Additional practices that separate a defensible implementation from a vulnerable one include enforcing attribute permissions that require authenticated encryption on any sensitive characteristic, managing bonding records so a lost or decommissioned device's keys can be revoked, authenticating firmware updates delivered over BLE so a bonded connection alone is not sufficient to push new code, and limiting the pairing window so a device only accepts new bonds during a deliberate, physically proximate action rather than indefinitely.

    How Should BLE Security Be Tested?

    BLE security should be tested with a combination of radio-level sniffing, protocol-level enumeration, and active manipulation, not just a code review of the stack configuration. Sniffer hardware captures the pairing exchange and connection traffic to verify whether Legacy pairing or LE Secure Connections is actually in use in the field, since firmware documentation and field behavior do not always match. GATT enumeration tools map every service and characteristic to confirm which ones require authentication and which do not. Fuzzing the BLE stack, sending malformed or out-of-sequence packets, tests whether the implementation handles unexpected input without crashing or entering an insecure state, and replay testing confirms whether previously captured commands can be resent successfully.

    What Should the Threat Model and FDA Submission Document?

    The threat model and FDA submission should document the specific BLE pairing method used, the rationale for that choice given the device's I/O capabilities, and the mitigations in place for each attack class relevant to the device's GATT design. Under the FDA's February 3, 2026 premarket cybersecurity guidance, reviewers expect this analysis to name BLE explicitly rather than fold it into a general wireless security statement. The submission should show which characteristics carry sensitive data or commands, what permission level protects each one, and how bonding and key management are handled across the device's lifecycle, including decommissioning.

    Common BLE vulnerabilities seen in medical devices

    Common BLE Cybersecurity Vulnerabilities

    See also: Embedded Cybersecurity Challenges MedTech, Radiology Information System (RIS) Software: Guide + Risks, and NFC and Medical Device Cybersecurity.

    Device Spoofing

    One of the prominent vulnerabilities in BLE cybersecurity is device spoofing. Hackers can impersonate legitimate BLE devices, tricking users into connecting to malicious devices. This allows attackers to access sensitive data or execute malicious actions. Device spoofing can be particularly dangerous when BLE devices are used for critical functions, such as in healthcare or industrial settings. Malicious actors could disrupt operations or compromise patient safety by spoofing essential devices.

    Man-in-the-Middle Attacks

    Another concerning vulnerability is the man-in-the-middle attack. In this scenario, an attacker can intercept communication between two BLE devices and manipulate the sent data. This enables them to eavesdrop on confidential information or even inject malicious commands into the communication. Man-in-the-middle attacks are a serious threat to the integrity and confidentiality of data exchanged between BLE devices. By exploiting this vulnerability, attackers can potentially steal sensitive information, such as login credentials or personal data, leading to serious privacy breaches.

    Replay Attacks

    Replay attacks involve recording and replaying data packets exchanged between BLE devices. This allows attackers to mimic legitimate devices and replay captured commands or actions. As a result, they can gain unauthorized access or manipulate the device’s behavior. Replay attacks pose a significant risk to the security of BLE devices. Attackers can use captured data to impersonate authorized users or devices. By replaying commands or actions, malicious actors can disrupt normal device operations or perform unauthorized actions without detection.

    Impact of BLE Cybersecurity Vulnerabilities

    Potential Risks and Threats

    Compromised BLE devices can expose users’ personal information, financial data, and physical safety. For instance, an attacker could gain unauthorized access to a smart lock’s authentication mechanism, allowing them to enter a person’s home undetected. Additionally, unauthorized access to medical devices could threaten patient safety and privacy. The interconnected nature of BLE devices means that a single vulnerability could have far-reaching consequences. A security breach in one device could potentially compromise an entire network of connected devices, amplifying the impact of the initial attack.

    Consequences of Ignoring BLE Cybersecurity

    If the cybersecurity vulnerabilities in BLE devices are ignored, the consequences can be dire. Organizations may face legal and financial repercussions due to data breaches and privacy violations. Users could suffer from identity theft, financial loss, or physical harm. Also, the trust in BLE technology could erode, hindering its growth and potential. Stakeholders in the BLE ecosystem must collaborate on improving cybersecurity measures, from implementing encryption protocols to regularly updating firmware to patch known vulnerabilities. By prioritizing cybersecurity, we can continue enjoying BLE technology’s benefits while minimizing the associated risks.

    Shipping a BLE-enabled device?

    Blue Goat Cyber is a medical-device-only cybersecurity firm. Our team runs the threat modeling, penetration testing, and FDA-facing documentation MedTech submissions live or die on. → Medical device penetration testing

    How Blue Goat Cyber Approaches This

    Blue Goat Cyber evaluates BLE implementations through architecture review, protocol-level testing, and penetration testing rather than a documentation-only assessment. We capture and analyze the actual pairing exchange in the field, enumerate GATT services and characteristics for unauthenticated access, and test companion mobile applications for the same trust assumptions that show up in firmware. In BLE engagements we most commonly find Just Works pairing left enabled in production, static keys reused across units, and GATT characteristics that expose configuration without authentication, each of which we map to a specific threat and mitigation in the submission package. Our team includes CISSP and OSCP-certified engineers with backgrounds in red team operations. Manufacturers preparing a BLE-enabled device for submission can start with our medical device penetration testing services.

    If you want one team to own the whole cybersecurity package, see our full-service FDA premarket cybersecurity submission support.

    Frequently Asked Questions

    Is BLE inherently secure for medical devices?

    No, BLE is a transport protocol whose security depends entirely on how pairing, bonding, and GATT permissions are configured. A device using BLE with Just Works pairing and unauthenticated characteristics is not secure simply because it uses BLE. Manufacturers have to make explicit configuration choices and document why they are appropriate for the device's risk profile.

    What is the difference between Legacy pairing and LE Secure Connections?

    Legacy pairing, used in earlier Bluetooth versions, derives its shared key in a way that a passive eavesdropper can recover if they capture the pairing exchange. LE Secure Connections, introduced in Bluetooth 4.2, uses Elliptic Curve Diffie-Hellman key exchange, so a passive observer cannot derive the resulting key even with a full capture of the exchange. Devices should use LE Secure Connections wherever the hardware supports it.

    Why is Just Works pairing considered risky?

    Just Works pairing provides no mechanism for either device to verify the identity of the other during the pairing exchange, which means it offers no resistance to a man-in-the-middle attack. It remains common because it requires no display or input on the peripheral device. Where a device has no I/O capability at all, application-layer authentication should compensate for what link-layer pairing cannot provide.

    What is GATT characteristic enumeration and why does it matter?

    GATT characteristic enumeration is the process of discovering every service and characteristic a BLE device exposes, along with the permission level protecting each one. It matters because unauthenticated read or write access on a single overlooked characteristic can expose telemetry or allow configuration changes without ever completing a real pairing. It is one of the most consistently productive tests in a BLE security assessment.

    Do resolvable private addresses solve BLE tracking risk?

    Resolvable private addresses reduce tracking risk by rotating the address a device broadcasts on a schedule known only to bonded peers, rather than exposing a static MAC address indefinitely. They do not eliminate tracking risk on their own if a companion app logs a persistent identifier elsewhere or if the rotation interval is too long. The address scheme has to be evaluated alongside the rest of the device's identifier handling.

    What does the FDA expect documented about BLE specifically?

    The FDA's February 3, 2026 premarket cybersecurity guidance expects the threat model to name BLE explicitly, describe the pairing method chosen and why, and map specific attack classes relevant to the device's GATT design to documented mitigations. A generic statement that the device uses encrypted wireless communication does not meet this expectation.

    CTA

    If your BLE implementation has not been tested at the protocol level, radio-based attacks against pairing and GATT access can be missed by a code review alone. Blue Goat Cyber can assess your BLE stack, pairing configuration, and companion app before your next FDA submission. Contact us to scope a wireless security assessment.

    Continue the BLE security series

    Dive deeper with these companion articles:

    About the author

    Christian Espinosa, Founder & CEO at Blue Goat Cyber

    Christian Espinosa, MBA · Founder & CEO, Blue Goat Cyber

    U.S. Air Force Academy graduate and veteran with 30+ years in cybersecurity. Founded Alpine Security in 2014 (acquired 2020), then Blue Goat Cyber in 2022. Has supported 275+ medical devices, with no cybersecurity-related rejections to date. Author of three books including The Smartest Person in the Room. Ironman triathlete and mountaineer.

    Read more about ChristianLinkedIn

    Where your device stands

    Find your stage in the FDA cybersecurity journey

    Answer one question about where your device is today. You get your stage, the next action to take, and the support that fits it.

    Find where my device stands

    Free readiness check

    How ready is your cybersecurity package for FDA review?

    Seven questions mapped to the FDA's February 3, 2026 premarket cybersecurity guidance. You get a score, a gap list by area, and the fastest next move. Takes about three minutes.

    Related services

    Put this into practice on your device

    Every Blue Goat Cyber engagement maps directly to FDA Section 524B and the SPDF - so the evidence you need lands in your submission, not in a separate report.

    Ready when you are

    Get FDA cleared without the cybersecurity headaches.

    30-minute strategy session. No cost, no commitment - just answers from people who've shipped 275+ FDA submissions.